Healthcare
HTGF et al. sell Symetis to Boston Scientific for $435m
Companies have developed complementary heart valve technologies
Bain and Cinven to take Stada private
Offer of €66 per share values the German pharmaceutical company at €5.3bn EV
Waterland's Atos bolts on Orthoparc
Acquisition will increase Atos's number of beds by 20%, raising the total to more than 300
CVC buys Metropolitan Hospital Group
GP injected capital from its 2013-vintage CVC Fund VI, which held a €10.5bn final close
Apposite's MIP bolts on Nuada's diagnostic imaging division
Acquisition will give the MRI, ultrasound and x-ray business a presence in central London
Ananda leads £2.5m series-A round for Repositive
Other investors include Amadeus Capital Partners and Force Over Mass Capital
Penta, Toscafund agree £75.2m Circle take-private
Deal for loss-making hospital operator would come six years after the business listed
DBAG buys two radiology practices
GP will merge the practices into a new group, securing a 56% stake in the new company
Nordic Capital, Avista place £2bn ConvaTec block
Two GPs sold a stake of nearly 20% to Danish biotechnology and pharmaceuticals group Novo
Auriga, Kreaxi, Alto in €2.4m round for Nosopharm
Nosopharm has raised a total of €4.2m in equity funding to date
CBPE's Medica lists with £150m market cap
GP sold around 70% of the UK-based teleradiology business after a four-year tenure
Qualitas buys genomics specialist Imegen
Deal saw the GP provide fresh capital from its 2014-vintage Q-Growth vehicle
SR One leads $30m series-B for Pulmocide
Company will use the extra funding to put its treatments through early clinical development
Rothschild et al. lead €34.4m series-B for MedLumics
New VC investors participated in the round, including Italian GP Innogest and Ireland-based Seroba Life Sciences
Irdi Soridec leads €16m funding round for Advicenne
Cemag Invest and MI Care also took part in the funding round for the French pharmaceutical business
Stada tells PE bidders to improve offers
German drug manufacturer reportedly received offers from Bain/Cinven and Advent/Permira consortiums
Kingsley invests £10m in Oxford Cannabinoid Technologies
Company will work alongside Oxford University to develop treatments for acute and chronic conditions
VRD and Bayern Kapital in €7.4m round for Lophius
Lophius will use the funding to accelerate diagnostic developments for tuberculosis using T cell technology
Waterland sells Mauritsklinieken to Holland Venture
Waterland Private Equity acquired a majority stake in the dermatological clinics group in 2010
Gimv in €7.8m series-B round for AgroSavfe
GP previously led a €5m round for the Belgian agro-biotech group in 2013
Gimv, Sofinnova in €43.5m round for Breath Therapeutics
Company will use the financing to conduct phase III trials of its inhalation therapy in Europe and the US
CVC backs Vitalia's SBO from Portobello
As part of the deal, existing shareholders will retain a minority stake in the business
Apposite acquires Mitie's social care arms in £2 hand-over
UK-listed service provider disposes of the loss-making divisions and will make payments to fund their trading losses
Vesalius leads €8.3m series-B for Omeicos
Backers in the investment round include KfW Bank, IBB Beteiligungsgesellschaft and Hich-Tech Gründerfonds